Atossa Therapeutics (ATOS) Stock Shouldn’t Be Ignored

Atossa Therapeutics ATOS Stock News

Atossa Therapeutics, Inc. (Nasdaq: ATOS) is up more than 6% in the premarket this morning, following up on the significant gains seen from the stock Friday. The gains started when the company announced its results for the fiscal first quarter of 2021.  Here’s what’s happening: Stop wasting your time! Start finding winning trades in minutes … Read more

Atossa Genetics (ATOS) Stock: Here’s Why It’s Flying

Atossa Therapeutics ATOS Stock News

Atossa Genetics Inc (NASDAQ: ATOS) is having an incredibly strong start to the trading session this morning. However, if you’re digging for press releases or SEC filings, you’re not going to find anything issued this morning. Nonetheless, there’s a very good reason for the gains today. Below, we’ll talk about: Why ATOS stock is headed … Read more

Atossa Genetics (ATOS) Stock: Gaining On Institutional Review Board News

Atossa Therapeutics ATOS Stock News

Atossa Genetics Inc (NASDAQ: ATOS) is making a run for the top in the market this morning, and for good reason. The company announced a positive result from an Institutional Review Board (IRB) review. Of course, the news excited investors, pushing the stock for the top. Today, we’ll talk about: The IRB news; what we’re … Read more

Atossa Genetics (ATOS) Stock: Climbing On Receipt Of $10 Million

Atossa Therapeutics ATOS Stock News

Atossa Genetics Inc (NASDAQ: ATOS) is making a run for the top in the market this morning, and for good reason. The company announced that its balance sheet has seen some improvement with the receipt of millions in funding. Of course, the news excited investors, pushing the stock on a run for the top. Today, … Read more

Atossa Genetics (ATOS) Stock: Rocketing On FDA Approval

Atossa Therapeutics ATOS Stock News

Atossa Genetics Inc (NASDAQ: ATOS) is flying early on in the trading session this morning, and for good reason. The company announced that it has received an FDA approval, exciting investors and sending the stock on a run for the top. Today, we’ll talk about: The FDA approval; what we’re seeing from ATOS stock as … Read more

Atossa Genetics (ATOS) Stock: Gaining On Expanded Access Results

Atossa Genetics Inc (NASDAQ: ATOS) is having a great start to the trading session this morning, and for good reason. The company announced positive results from the expanded access program surrounding a clinical-stage product. With the positive news in mind, excited investors are pushing the stock on a run for the top. Today, we’ll talk … Read more

Atossa Genetics (ATOS) Stock: Heading For The Top On Clinical Update

Atossa Genetics Inc (NASDAQ: ATOS) is having an overwhelmingly strong start to the trading session this morning after announcing news surrounding a clinical development program. Of course, the clinical update led to excitement among investors, sending the stock on a run for the top. Today, we’ll talk about: The clinical update; what we’re seeing from … Read more